Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D002555:Cerebrospinal Fluid / Q000382:microbiology; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage* / Q000009:adverse effects / Q000134:cerebrospinal fluid / Q000494:pharmacology / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007278:Injections, Spinal / Q000009:adverse effects; D007711:Klebsiella pneumoniae / Q000302:isolation & purification; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000382:microbiology; D008875:Middle Aged; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012706:Serratia marcescens / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D005839:Gentamicins